Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

被引：0
|
作者：
Ho, Chau
Bresliln, Monique
Chowdhury, Enayet
Doust, Jenny
Reid, Christopher M.
Davis, Barry R.
Simpson, Lara M.
Nelson, Mark R.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11020
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience
    Wright, JT
    Cushman, WC
    Davis, BR
    Barzilay, J
    Colon, P
    Egan, D
    Lucente, T
    Nwachuku, C
    Pressel, S
    Leenen, FHH
    Frolkis, J
    Letterer, R
    Walsh, S
    Tobin, JN
    Deger, GE
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 659 - 673
  • [22] Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease
    Dewland, Thomas A.
    Soliman, Elsayed Z.
    Davis, Barry R.
    Magnani, Jared W.
    Yamal, Jose-Miguel
    Piller, Linda B.
    Haywood, L. Julian
    Alonso, Alvaro
    Albert, Christine M.
    Marcus, Gregory M.
    JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1085 - 1092
  • [23] Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Haywood, L. Julian
    Ford, Charles E.
    Crow, Richard S.
    Davis, Barry R.
    Massie, Barry M.
    Einhorn, Paula T.
    Williard, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) : 2023 - 2031
  • [24] The relation of hypokalemia at 1 year to morbidity and mortality: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) experience
    Alderman, M.
    Piller, L.
    Ford, C.
    Davis, B.
    Einhorn, P.
    Cushman, W.
    Calhoun, D.
    Eckfeldt, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 671 - 671
  • [25] Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR
    Rahman, Mahboob
    Ford, Charles E.
    Cutler, Jeffrey A.
    Davis, Barry R.
    Piller, Linda B.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    Barzilay, Joshua I.
    Brown, Clinton D.
    Colon, Pedro J., Sr.
    Fine, Lawrence J.
    Grimm, Richard H., Jr.
    Gupta, Alok K.
    Baimbridge, Charles
    Haywood, L. Julian
    Henriquez, Mario A.
    Ilamaythi, Ekambaram
    Oparil, Suzanne
    Preston, Richard
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (06): : 989 - 1002
  • [26] Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, BR
    Cutler, JA
    Gordon, DJ
    Furberg, CD
    Wright, JT
    Cushman, WC
    Grimm, RH
    LaRosa, J
    Whelton, PK
    Perry, HM
    Alderman, MH
    Ford, CE
    Oparil, S
    Francis, C
    Proschan, M
    Pressel, S
    Black, HR
    Hawkins, CM
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (04) : 342 - 360
  • [27] Mortality and Morbidity During and After the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Cushman, William C.
    Davis, Barry R.
    Pressel, Sara L.
    Cutler, Jeffrey A.
    Einhorn, Paula T.
    Ford, Charles E.
    Oparil, Suzanne
    Probstfield, Jeffrey L.
    Whelton, Paul K.
    Wright, Jackson T., Jr.
    Alderman, Michael H.
    Basile, Jan N.
    Black, Henry R.
    Grimm, Richard H., Jr.
    Hamilton, Bruce P.
    Haywood, L. Julian
    Ong, Stephen T.
    Piller, Linda B.
    Simpson, Lara M.
    Stanford, Carol
    Weiss, Robert J.
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (01): : 20 - 31
  • [28] Stroke results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Oparil, S
    Davis, BR
    Nwachuku, C
    Pressel, S
    deLeon, B
    STROKE, 2004, 35 (01) : 235 - 235
  • [29] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [30] Impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) on physician prescribing patterns and patient utilization of antihypertensive medications
    Liu, X
    Yu, W
    Yokoyama, K
    VALUE IN HEALTH, 2004, 7 (03) : 334 - 334
12345